We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




High Cholesterol Linked to Risk of Tendinopathy

By LabMedica International staff writers
Posted on 03 Nov 2015
People with genetically determined very high cholesterol levels, as in familial hypercholesterolaemia, seem to be at greater risk of tendon pain, but it is not clear if those with lower, but still high levels might also be vulnerable to tendon injuries. More...


Tendons are the tough fibers connecting muscles and bones in the body. Mechanical stress as a result of obesity or excess body fat distribution, and overuse during the course of exercise or work, are thought to be among the leading causes of tendon injuries or tendinopathy.

Scientists at the Monash University (Melbourne, Australia) conducted a systematic review of six medical databases, looking for studies investigating links between blood fats and tendon abnormalities or pain. They found with 1,607 relevant articles, of which 17, involving 2,612 participants, and published between 1973 and 2014, were suitable for inclusion in the analysis. A meta-analysis was conducted for each of the four lipid measurements: total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG)), and their individual association with tendon structure or tendon pain.

Total cholesterol (TC) was significantly higher among individuals with tendon pain or rupture, with a mean difference (MD) of 0.66 mmol/L; HDL-C was significantly lower among individuals with tendon pain or rupture with MD equal to 0.19 mmol/L; and LDL-C was significantly higher among individuals with tendon pain or rupture, the MD was 1.00 mmol/L; and TG was significantly higher among individuals with tendon pain or rupture, the MD was 0.33 mmol/L. Furthermore, people with an unfavorable lipid profile were much more likely to have tendon injuries and higher levels of pain associated with musculoskeletal problems in their arms.

The authors concluded that the results of the review indicate that a relationship exists between an individual’s lipid profile and tendon health. However, further longitudinal studies are required to determine whether a cause and effect relationship exists between tendon structure and lipid levels. This could lead to advancement in the understanding of the pathoetiology and thus treatment of tendinopathy. The study was published on October 15, 2015, in the British Journal of Sports Medicine.

Related Links:

Monash University 



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.